AI Leaders Unite to Urge Bioweapons Safeguards on Synthetic DNA Suppliers
Executive Briefing
- Backs rare consensus among rival AI CEOs Altman, Amodei, Hassabis, and Wang on biosecurity legislation
- Urges policymakers to mandate screening of synthetic nucleic acid orders for dangerous biological sequences
- Warns AI's rapid progress may erode historical knowledge barriers that prevent bioweapon development
- Calls for order traceability and customer verification, arguing deterrence follows awareness of oversight
- Reflects OpenAI's broader push for credibility, including a federal AI vetting white paper and outreach to critics
Sponsored